Le, Anh N.
Harton, Joanna
Desai, Heena
Powers, Jacquelyn
Zelley, Kristin
Bradbury, Angela R.
Nathanson, Katherine L.
Shah, Payal D.
Doucette, Abigail
Freedman, Gary M.
Gabriel, Peter
Domchek, Susan M.
MacFarland, Suzanne P.
Maxwell, Kara N. http://orcid.org/0000-0001-8192-4202
Funding for this research was provided by:
National Cancer Institute (K08CA21531)
University of Pennsylvania (ITMAT MHB)
Burroughs Wellcome Fund (1017184)
Article History
Received: 4 December 2019
Accepted: 23 March 2020
First Online: 3 April 2020
Compliance with ethical standards
:
: Author SMD has received honoraria from Clovis, Bristol-Myers Squibb, and AstraZeneca. Author AB has an advisory role at AstraZeneca and Merck and has received research fund not related to this manuscript from AstraZeneca and Merck. All other authors declare that they have no potential conflict of interest.
: All studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: This single-institution human subjects' retrospective chart review is qualified for exempt status and does not require informed consent or waiver of consent.